Brain Metabolic Network of PET in Patients With Advanced Non-Small Cell Lung Cancer

Advanced Non-small-cell Lung Cancer Clinical Trial

Official title:

The Fifth Affiliated Hospital of Sun Yat-sen University

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05380908
• Other study ID #: K059(2021-059)
• Status: Completed
• Start date: June 1, 2017
• Est. completion date: February 28, 2021

Study information

• Verified date: May 2022
• Source: Fifth Affiliated Hospital, Sun Yat-Sen University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study is a retrospective study, screening patients with systemic PET / CT scan in our department, enrolling the ones who meet the criteria, collect their information and resting state brain PET images.Then make the brain metabolic network analysis and statistical analysis to explore the PET brain metabolic network of non-small cell lung cancer patients and the effect of chemotherapy drugs on brain metabolic network in patients with advanced lung cancer.

Description:

1. Enroll Participants 2. Collect PET/CT Images 3. Images Analysis 4. Statistical Analysis

Recruitment information / eligibility

• Status: Completed
• Enrollment: 90
• Est. completion date: February 28, 2021
• Est. primary completion date: February 28, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Patients with advanced non-small cell lung cancer without any treatment and pathological confirmed non-small cell lung cancer.

Exclusion Criteria:

• Brain tumors (primary or metastasis), previous surgery, radiotherapy, chemotherapy, stroke, head trauma, psychiatric history (insomnia, depression, mania, schizophrenia and other psychiatric disorders), or history of drug dependence (e. g. sedatives, sleeping pills or sedatives)

Related Conditions & MeSH terms

• Advanced Non-small-cell Lung Cancer
• Carcinoma, Non-Small-Cell Lung
• Lung Neoplasms

Intervention

Other:
• None of any intervention
The patients did not have any intervention.

Locations

Country	Name	City	State
China	PET/CT	Zhuhai	Guangdong

Sponsors (1)

Lead Sponsor	Collaborator
Fifth Affiliated Hospital, Sun Yat-Sen University

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Death		1-5 years